Cooperative Agreement HT94252420003
Award Date
6/1/24
Completion Date
5/31/28
Dollars Obligated
$1.9M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Cooperative Agreement
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
This Cooperative Agreement award of $638,820 from the Defense Health Agency supports an mRNA multivalent approach to develop an innovative malaria vaccine. The project, funded through the Military Medical Research and Development program (CFDA 12.420), aims to broaden the immune targets against malaria infection by including both pre-erythrocytic-stage antigens and mosquito saliva antigens. The Geneva Foundation, a non-profit research organization, will conduct this research over a 3-year period...
The Department of the Army Medical Command awarded a $1,157,298 cooperative agreement to The Geneva Foundation of Tacoma, WA from September 1, 2022 through August 31, 2025. The award will support research under the Military Medical Research and Development program (CFDA 12.420) to rationally design an immunogen for protection against Plasmodium vivax malaria. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
The Department of Defense's Defense Health Agency has awarded a $4,876,076 Project Grant to Washington University to develop a novel point-of-care multiplex device for classifying molecular phenotypes of acute respiratory distress syndrome and sepsis. This research falls under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The grant has a performance...
The Geneva Foundation was awarded a $1,597,740 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2022 to June 2026 to develop new methods for accessing extracellular vesicle MDM2 DNA cargo as a potential liposarcoma biomarker. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
This Cooperative Agreement, awarded by the Defense Health Agency, provides $568,275 in funding to Conserv Bioscience LIMITED, a foreign-owned for-profit organization, to develop an mRNA multivalent approach including pre-erythrocytic-stage antigens and mosquito saliva antigens to broaden the immune targets against malaria infection. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $573,416 project grant to The Geneva Foundation to conduct a study titled "PRE-DIAGNOSTIC SERUM CONCENTRATIONS OF PER- AND POLYFLUOROALKYL SUBSTANCES AND RISK OF TESTICULAR GERM CELL TUMORS AMONG ACTIVE-DUTY SERVICEMEN." The 3-year grant, which began on Sep 30, 2023, will support research investigating the relationship between exposure to per- and polyfluoroalkyl substances...
The federal Project Grant award of $6,663,794.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY", is focused on delivering incremental funding to advance precision with return-to-duty decisions for military personnel. The primary awardee is The Geneva Foundation, a non-profit organization based in Tacoma, Washington, that...
The U.S. Defense Health Agency awarded a $909,510 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Geneva Foundation, a non-profit research organization in Tacoma, Washington. The grant supports advanced biomedical research to develop precision therapy for the eradication of brain metastatic breast cancer. The 3-year grant, running from May 2025 to April 2028, will fund innovative research, development, and clinical support services focused on...
The Defense Health Agency awarded a $1,009,750.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation in Tacoma, Washington. The grant, awarded on August 1, 2025, supports the "Genomic and Functional Characterization of Chemoresistance in Small Cell Lung Cancer" research project with a completion date of July 31, 2028. The Geneva Foundation, a non-profit organization focused on medical research and development for the U.S....
This Cooperative Agreement award from the Uniformed Services University of the Health Sciences (CFDA 12.750 - Uniformed Services University Medical Research Projects) provides $744,897 in funding to The Geneva Foundation, a non-profit organization, from August 30, 2024 to August 29, 2026. The award supports the 4D BIO3 BIODEFENSE INITIATIVE, focused on advancing military medical research, education, and training to improve healthcare outcomes for military personnel, veterans, and public health...